LBS-008 / Tinlarebant
Category: Pharmaceutical
Exhibitor: LIN BIOSCIENCE, INC.
Booth No: M434
Characteristic
An innovative, once-daily oral tablet acting as an early intervention for inherited ophthalmic rare disease, Stargardt Disease (STGD1) and Geographic Atrophy (GA), a late stage dry Age-Related Macular Degeneration (AMD).
We welcome you to visit us to
Other Products
Products you may be interested in
Highest Rated Products